Mitra C, Ganguly D K, Guha S R
J Pharm Pharmacol. 1984 Jun;36(6):408-10. doi: 10.1111/j.2042-7158.1984.tb04411.x.
N-Carbamoyl-2-(2,6-dichlorophenyl)acetamidine HCl (LON 954), a tremorogenic drug, inhibited MAO activity in various tissue preparations in a reversible, competitive manner showing some degree of selectivity towards type-B MAO.
N-氨基甲酰基-2-(2,6-二氯苯基)乙脒盐酸盐(LON 954)是一种致震颤药物,它以可逆的、竞争性的方式抑制各种组织制剂中的单胺氧化酶(MAO)活性,对B型MAO表现出一定程度的选择性。